Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 3—March 2019
Synopsis

Cross-Border Movement of Highly Drug-Resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010–2015

Arnold Bainomugisa, Sushil Pandey, Ellen Donnan, Graham Simpson, J’Belle Foster, Evelyn Lavu, Stenard Hiasihri, Emma S. McBryde, Rendi Moke, Steven Vincent, Vitali Sintchenko, Ben J. Marais, Lachlan J.M. Coin, and Christopher CoulterComments to Author 
Author affiliations: Pathology Queensland, Brisbane, Queensland, Australia (A. Bainomugisa, S. Pandey, C. Coulter); The University of Queensland, Brisbane (A. Bainomugisa, L.J.M. Coin); Queensland Department of Health, Brisbane (E. Donnan, C. Coulter); Cairns Tuberculosis Unit, Cairns, Queensland, Australia (G. Simpson, S. Vincent); James Cook University, Townsville, Queensland, Australia (J. Foster, E.S. McBryde); Central Public Health Laboratory, Port Moresby, Papua New Guinea (E. Lavu); Western Province Health Office, Daru, Papua New Guinea (S. Hiasihri); Port Moresby General Hospital, Port Moresby (R. Moke); Westmead Hospital, Sydney, New South Wales, Australia (V. Sintchenko); The University of Sydney, Sydney (V. Sintchenko, B.J. Marais)

Main Article

Table 1

Characteristics of Papua New Guinea residents infected with cross-border TB isolates, Torres Strait Protected Zone, 2010–2015, by lineage*

Characteristic
 Total no. (%)
 Lineage p value†
Beijing
 Euro-American
Age, y 0.739
<15 19 (19.0) 15 4
15–24 31 (31.0) 26 5
25–34 24 (24.0) 19 5
35–49 18 (18.0) 13 5
>50
 8 (8.0)
 6
 2
Year 0.324
2010 29 (29.0) 22 7
2011 42 (42.0) 33 9
2012 13 (13.0) 12 1
2013 2 (2.0) 1 1
2014 8 (8.0) 5 3
2015
 6 (6.0)
 6
 0
Sex 0.876
F 45 (45.0) 35 10
M
 55 (55.0)
 44
 11
Sputum smear 0.599
Negative 46 (46.0) 34 12
Positive
 54 (54.0)
 45
 9
HIV status 0.234
Unknown 26 (26.0) 20 6
Negative 73 (73.0) 59 14
Positive
 1 (1.0)
 0
 1
Previous TB episode 0.653
No 87 (87.0) 68 19
Yes
 13 (13.0)
 11
 2
Diagnostic delay, d 0.484
0–30 53 (53.0) 44 9
31–60 18 (18.0) 14 4
>61
 29 (29.0)
 21
 8
MDR or XDR <0.001
No 69 (69.0) 48 21
Yes
 31 (31.0)
 31
 0
Type of TB 0.741
Pulmonary 53 (53.0) 43 10
Extrapulmonary 7 (7.0) 5 2
Both
 40 (40.0)
 31
 9
Started TB treatment 0.472
No 22 (22.0) 15 7
Yes
 78 (78.0)
 64
 14
TB treatment outcome 0.216
Transferred or lost to follow-up 66 (66.0) 52 14
Cure or complete treatment 22 (22.0) 15 7
Defaulted 3 (3.0) 3 0
Died 9 (9.0) 9 0

*MDR, multidrug resistant; TB, tuberculosis; XDR, extensively drug resistant.
†p value calculated by using Fisher exact test.

Main Article

Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external